Constructive Bio
Constructive Bio provides a platform for genome and polymer synthesis, having pioneered methods for reprogramming the genetic code of living organisms to make them resistant to viruses and capable of producing synthetic polymers and performing entirely new functions. The technology has applications across novel therapeutics, antibiotics, enhanced agriculture, manufacturing, and materials. Founded in 2022 and…
Funding snapshot
About
Constructive Bio provides a platform for genome and polymer synthesis, having pioneered methods for reprogramming the genetic code of living organisms to make them resistant to viruses and capable of producing synthetic polymers and performing entirely new functions. The technology has applications across novel therapeutics, antibiotics, enhanced agriculture, manufacturing, and materials. Founded in 2022 and headquartered in Saffron Walden, United Kingdom, Constructive Bio has raised $75M in Series A funding from investors including Ahren, Amadeus Capital, OMX Ventures, General Inception, Paladin Capital, Fine Structure Ventures, ND Capital, and LongeVC. The company's synthetic biology platform enables the creation of organisms with rewritten genetic codes that can incorporate non-standard amino acids into proteins, opening possibilities for producing novel biomaterials and therapeutics that cannot be made by natural biological systems.
Business model
Genomics > Applied Genomics > Synthetic Biology,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.